Splose Raises $32 Million Series A to Scale Allied Health Practice…

Team S · 2026-02-25T12:52:46.000Z

Splose, an allied health software provider based in Australia, has successfully completed a A$46 million (approximately US$32 million) Series A funding round to expand its end-to-end practice management platform across key markets including Australia, the United Kingdom, and New Zealand. The fresh capital will enable the company to grow its operations, accelerate deeper integration of artificial intelligence tools, and streamline workflows for allied health professionals. Founded in 2018, Splose offers a comprehensive operating system for allied health practices that supports scheduling, billing, payments, invoicing, reporting and more. The platform is currently used by more than 20,000 allied health practitioners across its markets, helping clinics and individual providers manage administrative workflows more efficiently. Funding Round and Investors – The Series A was led by Spectrum Equity, a US-based growth equity firm, with participation from Athletic Ventures. These investors are backing Splose’s expansion strategy that includes scaling teams in Adelaide, Sydney, Melbourne and London, enhancing AI-driven features within the platform, and facilitating seamless payment solutions for its users. In addition to Splose’s raise, the healthcare sector saw other funding activity in the region. New Zealand medtech company Wellumio closed the first close of its pre-Series A round with NZ$7.28 million (US$4.3 million) to develop its portable, AI-augmented stroke imaging device. Also, healthcare software provider Alcidion secured regulatory approvals in Australia and the UK for its latest AI-assisted clinical analysis tool, while NSW Health launched a personalised vaccination schedule tool amid rising measles cases across the state. Splose’s growth reflects the dynamic allied health technology landscape in the ANZ region, where digital solutions are increasingly adopted to simplify clinical operations and support better patient outcomes.

Member Login Get Access

Splose Raises $32 Million Series A to Scale Allied Health Practice… | Newnex